Featured Milestone
FDA Grants Breakthrough Device Designation to R-FIX™
The U.S. Food and Drug Administration granted Breakthrough Device Designation to the R-FIX™ platform, recognizing its potential to address important unmet needs in pediatric spinal deformity surgery and adult proximal junctional kyphosis prevention. The designation supports continued collaboration with the FDA throughout product development.
